{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:29:35Z","timestamp":1790990975227,"version":"4.1.0"},"reference-count":43,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dentistry Journal"],"abstract":"<jats:p>The aim of this systematic review is to present an up-to-date review of available publications investigating the cellular mechanisms initiating the development of medication-related osteonecrosis of the jaw caused by zoledronic acid. Electronic searches of MEDLINE\/PubMed and Scopus were conducted on the 3 June 2019. A total of 804 publications were identified, of which 11 met the inclusion criteria and were, therefore, included in this study. All the included studies were in vitro studies investigating various human cells. The current review found that zoledronic acid in various concentrations increased apoptosis and decreased migration and proliferation of epithelial cells, fibroblasts, osteoblasts, endothelial cells and dental pulp stem cells, which can affect local tissue homeostasis. The consequences of zoledronic acid were found to be both time- and dose-dependent. The pathophysiology of medication-related osteonecrosis of the jaw is likely a multifactorial process involving prolonged wound healing, chronic inflammation and altered bone remodelling following the administration of zoledronic acid. Further research is needed to identify the exact pathophysiology to optimise management and treatment.<\/jats:p>","DOI":"10.3390\/dj9080085","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T12:59:24Z","timestamp":1627649964000},"page":"85","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology"],"prefix":"10.3390","volume":"9","author":[{"given":"Aya","family":"Alsalih","sequence":"first","affiliation":[{"name":"Faculty of Odontology, Malm\u00f6 University, 205 06 Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annica","family":"Dam","sequence":"additional","affiliation":[{"name":"Faculty of Odontology, Malm\u00f6 University, 205 06 Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Lindberg","sequence":"additional","affiliation":[{"name":"Department of Oral Pathology, Faculty of Odontology, Malm\u00f6 University, 205 06 Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Truedsson","sequence":"additional","affiliation":[{"name":"Department of Oral Maxillofacial Surgery and Oral Medicine, Faculty of Odontology, Malm\u00f6 University, 205 06 Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw\u20142014 Update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.oooo.2018.11.012","article-title":"Medication-related osteonecrosis of the jaw unrelated to bisphosphonates and denosumab\u2014A review","volume":"127","author":"King","year":"2019","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"104659","DOI":"10.1016\/j.oraloncology.2020.104659","article-title":"New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws","volume":"106","author":"Bennardo","year":"2020","journal-title":"Oral Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/odi.13160","article-title":"Workshop of European task force on medication-related osteonecrosis of the jaw\u2014Current challenges","volume":"25","author":"Schiodt","year":"2019","journal-title":"Oral Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.oooo.2018.08.015","article-title":"Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study","volume":"126","author":"Hallmer","year":"2018","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.coms.2015.06.003","article-title":"The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors","volume":"27","author":"Dodson","year":"2015","journal-title":"Oral Maxillofac. Surg. Clin. N. Am."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.oooo.2014.05.006","article-title":"Osteonecrosis of the jaw in patients treated with oral and intravenous bisphosphonates: Experience in Sweden","volume":"118","author":"Hallmer","year":"2014","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/odi.12708","article-title":"Risk factors for medication-related osteonecrosis of the jaws: A systematic review","volume":"24","author":"McGowan","year":"2018","journal-title":"Oral Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/ors.12329","article-title":"Medication-related osteonecrosis of the jaw\u2014A current review","volume":"11","author":"Domah","year":"2018","journal-title":"Oral Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.165.3899.1262","article-title":"Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo","volume":"165","author":"Fleisch","year":"1969","journal-title":"Science"},{"key":"ref_12","unstructured":"Nanci, A. (2018). Ten Cate\u2019s Oral Histology: Development, Structure, and Function, Elsevier. [9th ed.]."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11926-003-0071-z","article-title":"Matrix vesicles and calcification","volume":"5","author":"Anderson","year":"2003","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: Similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos. Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/odi.12632","article-title":"Time to onset of bisphosphonate-related osteonecrosis of the jaws: A multicentre retrospective cohort study","volume":"23","author":"Fung","year":"2017","journal-title":"Oral Dis."},{"key":"ref_17","unstructured":"(2019, March 19). PRISMA Guidelines. Available online: http:\/\/prisma-statement.org\/prismastatement\/Checklist.aspx."},{"key":"ref_18","unstructured":"(2019, June 03). Rayyan QCRI. Available online: https:\/\/rayyan.qcri.org\/welcome."},{"key":"ref_19","unstructured":"(2019, July 08). ToxRtool. Available online: https:\/\/ec.europa.eu\/jrc\/en\/scientific-tool\/toxrtool-toxicological-data-reliability-assessment-tool."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1755-1536-3-6","article-title":"A novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosis","volume":"3","author":"Scheper","year":"2010","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.archoralbio.2010.11.003","article-title":"Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts","volume":"56","author":"Ravosa","year":"2011","journal-title":"Arch. Oral Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2141.2008.07504.x","article-title":"Effect of zoledronic acid on oral fibroblasts and epithelial cells: A potential mechanism of bisphosphonate-associated osteonecrosis","volume":"144","author":"Scheper","year":"2009","journal-title":"Br. J. Haematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.12659\/MSM.911579","article-title":"Epidermal Growth Factor Reverses the Inhibitory Effects of the Bisphosphonate, Zoledronic Acid, on Human Oral Keratinocytes and Human Vascular Endothelial Cells In Vitro via the Epidermal Growth Factor Receptor (EGFR)\/Akt\/Phosphoinositide 3-Kinase (PI3K)","volume":"25","author":"Wang","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1600-0714.2012.01173.x","article-title":"Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: An in vitro model","volume":"41","author":"Saracino","year":"2012","journal-title":"J. Oral Pathol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1139\/cjpp-2016-0348","article-title":"Effect of zoledronate, a third-generation bisphosphonate, on proliferation and apoptosis of human dental pulp stem cells","volume":"96","author":"Pourgonabadi","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00784-015-1528-y","article-title":"PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells","volume":"20","author":"Anitua","year":"2016","journal-title":"Clin. Oral Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3892\/ijmm.2016.2582","article-title":"Zoledronic acid suppresses transforming growth factor-\u03b2-induced fibrogenesis by human gingival fibroblasts","volume":"38","author":"Komatsu","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bjoms.2016.05.030","article-title":"Influence of zoledronic acid on proliferation, migration, and apoptosis of vascular endothelial cells","volume":"54","author":"Lang","year":"2016","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.3892\/mmr.2016.5834","article-title":"Zoledronate induces autophagic cell death in human umbilical vein endothelial cells via Beclin-1 dependent pathway activation","volume":"14","author":"Lu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jds.2014.07.004","article-title":"Effects of zoledronic acid on osteoblasts in three-dimensional culture","volume":"10","author":"Thibaut","year":"2015","journal-title":"J. Dent. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00784-009-0365-2","article-title":"Bisphosphonates: Restrictions for vasculogenesis and angiogenesis: Inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro","volume":"15","author":"Ziebart","year":"2011","journal-title":"Clin. Oral Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1590\/abd1806-4841.20164741","article-title":"Wound healing\u2014A literature review","volume":"91","author":"Gonzalez","year":"2016","journal-title":"An. Bras. Dermatol. Soc. Bras. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature07039","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nature"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1601-0825.2010.01720.x","article-title":"Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro","volume":"17","author":"Walter","year":"2011","journal-title":"Oral Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tibs.2003.12.003","article-title":"I\u03baB kinases: Key regulators of the NF-\u03baB pathway","volume":"29","author":"Yamamoto","year":"2004","journal-title":"Trends Biochem. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000152915","article-title":"Osteonecrosis of the jaw: An update and review of recommendations","volume":"189","author":"Novince","year":"2008","journal-title":"Cells Tissues Organs"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.joms.2007.11.035","article-title":"Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy","volume":"66","author":"Sedghizadeh","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11914-018-0474-4","article-title":"Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw","volume":"16","author":"Chang","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.trsl.2011.05.004","article-title":"Actin cytoskeleton in myofibroblast differentiation: Ultrastructure defining form and driving function","volume":"158","author":"Sandbo","year":"2011","journal-title":"Transl. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4709572","DOI":"10.1155\/2016\/4709572","article-title":"Mesenchymal stem cells derived from dental pulp: A review","volume":"2016","year":"2016","journal-title":"Stem Cells Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-Induced Exposed Bone (Osteonecrosis\/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1177\/009127002762491316","article-title":"Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases","volume":"42","author":"Chen","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminoncol.2010.06.003","article-title":"The molecular basis of bisphosphonate activity: A preclinical perspective","volume":"37","author":"Green","year":"2010","journal-title":"Semin. Oncol."}],"container-title":["Dentistry Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2304-6767\/9\/8\/85\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:37:52Z","timestamp":1760164672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2304-6767\/9\/8\/85"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,30]]},"references-count":43,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["dj9080085"],"URL":"https:\/\/doi.org\/10.3390\/dj9080085","relation":{},"ISSN":["2304-6767"],"issn-type":[{"value":"2304-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,30]]}}}